Last updated on June 2019

Study to Assess the Efficacy and Safety of Raxone in LHON Patients


Brief description of study

LEROS is an open-label interventional Phase IV study, designed to further assess the efficacy and safety of Raxone in the long-term treatment of LHON patients.

Clinical Study Identifier: NCT02774005

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.